Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 41 - 50 of 123 results for "Biotech"

ETPs attracting money despite volatility

KANIKA SOOD  |  TUESDAY, 13 NOV 2018
... over international equity ETFs, which have become more expensive as the Australian dollar has weakened," Neiron said. New biotech ETF Last week, ETF Securities launched a new ETF that will invest in 120 international healthcare biotech stocks for a fee ...

Praemium FUA surpasses $8bn

KARREN VERGARA  |  FRIDAY, 13 JUL 2018
... at the time of publication, the highest since January 2007. We recently profiled Ohanessian's career from running a biotech company to spearheading Praemium's growth trajectory. Read about it here.

Fintech success insignificant so far: Fahy

JAMIE WILLIAMSON  |  MONDAY, 5 JUN 2017
... operating in the 'toy domain', with the industry yet to be disrupted in any meaningful way. Drawing a comparison to the biotech sector, Association of Superannuation Funds of Australia chief executive Martin Fahy said fintech success stories don't stack ...

TelstraSuper commits to innovation

EMMA RAPAPORT  |  TUESDAY, 30 MAY 2017
... chapter for TelstraSuper. We'll be supporting promising opportunities in the fields of healthcare, technology, cleantech and biotech based on scientific research and aiming to turn these into outstanding returns for our members," Miller said. "Unlike ...

Arnhem SMA rating receives upgrade

JAMIE WILLIAMSON  |  THURSDAY, 2 MAR 2017
Lonsec's rating of Arnhem Investment Management's global separately managed account was upgraded in its latest round of reviews. Arnhem's global SMA, the Australia+ SMA, is now 'Recommended' by the ratings house, with Lonsec highlighting its "highly ...

Brandon Capital to build largest Commonwealth VC fund

JAMIE WILLIAMSON  |  WEDNESDAY, 14 DEC 2016
... world market," Curnock Cook said. The BTF will be Australia's largest life sciences fund, with private investors including biotech company CSL Limited, AustralianSuper, HESTA, Statewide and Hostplus. The fund is expected to make its first investments ...

Low return world a boon for VC

JAMIE WILLIAMSON  |  THURSDAY, 20 OCT 2016
... than the long-term benefits of innovation. However, investment manager QIC says that the recent success of one of its biotech investments, Hatchtech, demonstrates the great potential of the market. Melbourne-based Hatchtech is the developer of a next ...

Hostplus tripling venture capital exposure

DARREN SNYDER  |  THURSDAY, 15 SEP 2016
... with a focus on technology, including: M.H. Carnegie & Co (general and medical technology), Brandon Capital Partners (biotech), and Blackbird Ventures (software).

Capital stewards create value on Main Street

DARREN SNYDER  |  TUESDAY, 6 SEP 2016
... said capital stewardship is not about an ESG or values-based overlay because that could be anybody's values. He cited biotech and genetic modification as an example where values-based investing becomes tricky. He said another example at Aberdeen was ...

New board members at Sunsuper

DARREN SNYDER  |  TUESDAY, 12 JUL 2016
Sunsuper is welcoming two new board members this week and the appointments will form an integral part of a cultural and digital transformation at the $35 billion fund. Joining Sunsuper's board are Theresa Moltoni and Professor Mark Harvey. The pair ...